Beyond Neyman–Pearson: E-values enable hypothesis testing with a data-driven alpha
A standard practice in statistical hypothesis testing is to mention the <i>P</i>-value alongside the accept/reject decision. We show the advantages of mentioning an e-value instead. With <i>P</i>-values, it is not clear how to use an extreme observation (e.g. [Formula: see text]) for getting better frequentist decisions. With e-values it is straightforward, since they provide Type-I risk control in a generalized Neyman-Pearson setting with the decision task (a general loss function) determined post hoc, after observation of the data-thereby providing a handle on "roving [Formula: see text]'s." When Type-II risks are taken into consideration, the only admissible decision rules in the post hoc setting turn out to be e-value-based. Similarly, if the loss incurred when specifying a faulty confidence interval is not fixed in advance, standard confidence intervals and distributions may fail, whereas e-confidence sets and e-posteriors still provide valid risk guarantees. Sufficiently powerful e-values have by now been developed for a range of classical testing problems. We discuss the main challenges for wider development and deployment.
Authors
- Peter Grünwald (ORCID: https://orcid.org/0000-0001-9832-9936)
Institutions
- Leiden University (NL)
- Centrum Wiskunde & Informatica (NL)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1073/pnas.2302098121
- Citations
- 10
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 7.09